The molecule that powers every cell in your body may also hold the key to unlocking your body’s full healing potential during cancer treatment.
Take a breath. In that single inhale, you’ve drawn in the molecule that powers virtually every function in your body. Oxygen fuels your muscles, feeds your brain, and drives the microscopic engines inside each of your 37 trillion cells. Without it, life as we know it simply stops.
But here’s the paradox: the very molecule that sustains life can also damage it. Oxygen can be both a healer and a hazard, a protector and a disruptor. And in the world of cancer, this duality isn’t just a scientific curiosity , it’s a fundamental insight that is reshaping how we think about treatment, recovery, and the body’s remarkable capacity to heal itself.
The Spark That Keeps the Engine Running
To understand oxygen’s role in the body, think of your cells as tiny power plants. Each one contains hundreds of structures called mitochondria — the cell’s energy generators. These mitochondria take in oxygen and nutrients from the food you eat, and through a process called oxidative phosphorylation, convert them into ATP (adenosine triphosphate), the universal energy currency that powers everything from muscle contraction to immune cell activation to DNA repair.
The process works through what biochemists call the electron transport chain — a series of protein complexes embedded in the inner mitochondrial membrane. Think of it as a molecular relay race: electrons pass from one complex to the next, and at each handoff, it captures energy to drive ATP production. At the final stage, oxygen acts as the essential last runner — accepting those electrons and combining them with hydrogen to form water. Without oxygen waiting at the finish line, the entire chain backs up, and energy production grinds to a halt (1, 2).
The numbers tell the story. When oxygen is available, a single molecule of glucose yields approximately 36 to 38 molecules of ATP. Without oxygen, cells fall back on a far less efficient emergency pathway, anaerobic glycolysis — which produces just 2 ATP per glucose. It’s the difference between running a city on a full-power grid and running it on a handful of portable generators. The lights may flicker on, but the system can’t sustain itself for long.
That is why sustained and efficient oxygen delivery is so profoundly important for maintaining health and overcoming disease. Every organ, every tissue, every healing process in the body depends on a steady, adequate supply of oxygen to function at full capacity.
The Spark That Can Also Start a Fire
Here’s where the paradox deepens. The same metabolic processes that use oxygen to generate energy also produce byproducts, highly reactive molecules known as reactive oxygen species (ROS), sometimes called free radicals. These molecules are chemically unstable; they carry unpaired electrons that make them eager to react with nearby proteins, fats, and even DNA.
Figure 1. Mild, bioregulated oxidative stress supports healthy cellular function. When the body’s antioxidant defenses are overwhelmed, the resulting uncontrolled oxidative stress drives DNA damage and genomic instability (© 2026 Hope4Cancer Treatment Centers, All Rights Reserved).
If that sounds dangerous, it can be. But not always. The body, it turns out, uses these reactive molecules strategically for critical metabolic transformations. In small, carefully controlled amounts, ROS serve as essential signaling molecules. Mitochondria generate them as a natural byproduct of energy production; immune cells produce them on purpose, e.g., neutrophils and macrophages fire controlled ROS bursts like molecular weapons to neutralize pathogens and clear damaged tissue.
Think of them as the body’s internal alarm system. In addition to fulfilling their immediate purpose, the process also alerts cells to incoming pathogens, triggers immune defenses, regulates blood vessel function, and can initiate apoptosis—the orderly self-destruction of damaged or abnormal cells before they can become a threat. This process of mild, bioregulated oxidative stress is not a flaw in the system; it is a feature. It’s how the body maintains itself, stays clean, remains functional, and remains responsive to danger (Figure 1) (3).
To manage these reactive molecules, the body maintains a sophisticated antioxidant defense system—a team of specialized enzymes that work in sequence, like a decontamination crew. Superoxide dismutase (SOD) catalyzes the first step, converting superoxide to hydrogen peroxide. Catalase and glutathione peroxidase then break hydrogen peroxide down into harmless water and oxygen (4). Overseeing this entire defense network is a protein called Nrf2, often described as the master switch of the antioxidant response. When oxidative stress is detected, Nrf2 activates a broad suite of protective genes, essentially telling the cell to ramp up its defenses (5). This mechanism of oxidative preconditioning, which involves a brief, mild oxidative signal that trains the system to respond to future challenges, becomes possible through this mechanism.
The trouble begins when ROS production overwhelms these defenses. When reactive molecules accumulate faster than SOD, catalase, and glutathione can neutralize them—due to chronic inflammation, mitochondrial dysfunction, environmental pollutants, heavy metal exposure, radiation, poor nutrition, or lifestyle factors such as obesity —the result is uncontrolled oxidative stress. Instead of precise signaling, you get indiscriminate damage: proteins misfold, cell membranes are compromised, and DNA is mutated. This kind of oxidative chaos doesn’t just injure cells — it creates the genomic instability that can drive healthy cells toward becoming cancerous ones (6). So the question is never simply whether oxidative stress is “good” or “bad.” The question is whether it’s regulated or runaway — whether the spark is lighting a controlled campfire or an uncontrolled wildfire.
When Tumors Steal the Breath From Their Own Neighborhood
Now, let’s turn to one of the most studied and most consequential phenomena in modern cancer biology: localized oxygen deficiency.
Solid tumors grow aggressively. They divide rapidly, piling cells on top of cells, expanding outward and inward with little regard for the infrastructure around them. But there’s a problem: they often outgrow their own blood supply. The blood vessels that feed a tumor are typically disorganized, leaky, and insufficient, unable to deliver oxygen to the tumor’s interior at the rate the tissue demands.
The result is a condition called tumor hypoxia pockets within the tumor where oxygen levels plummet to a fraction of what surrounding healthy tissue receives. This paradox a body abundant in oxygen yet harboring pockets of suffocating tissue has become one of the most-studied phenomena in modern oncology.
And the consequences are far-reaching.
At the molecular level, low oxygen activates the protein hypoxia-inducible factor 1-alpha (HIF-1α), a master switch that reprograms tumor cells for survival under hypoxic conditions. HIF-1α triggers the growth of new (but often dysfunctional) blood vessels and suppresses the immune system within the tumor microenvironment (7, 8).
HIF-1α also forces a dramatic metabolic shift. Remember the difference between oxygen-fueled energy production (36–38 ATP) and the anaerobic backup (just 2 ATP)? Hypoxic tumors become locked in that inefficient mode — a phenomenon scientists call the Warburg effect. To compensate for the low energy yield, tumor cells consume glucose at an extraordinary rate, producing massive quantities of lactate as a byproduct. This acidifies the surrounding tissue, creating a toxic microenvironment that further suppresses immune cells and promotes tumor invasion (9).
Think of it this way: the immune system is the body’s surveillance team, constantly patrolling for abnormal cells. But in a hypoxic, acidic tumor, it’s as if someone has turned off the lights, locked the doors, and filled the room with smoke. Natural killer cells lose their potency. T-cells, the immune system’s most targeted cancer fighters become sluggish and dysfunctional. Meanwhile, the tumor actively recruits immunosuppressive cells that act as bodyguards, shielding cancer cells from immune attack (8).
The described immune and other metabolic dysfunctions are so central to how cancer develops and sustains itself that they are prominently highlighted as part of the 11 Integrative Hallmarks of CancerTM described in our book Cancer Outsmarted the key biological mechanisms that drive oncogenesis and integrative oncology seeks to address (10).
Figure 2. Comparison of healthy and cancer cell metabolism, highlighting differences in oxygen utilization and energy production. Although cancer cannot be reduced solely to a metabolic disease, metabolic reprogramming is a defining and well-established feature of malignant transformation.
Why This Matters for Every Cancer Patient
The clinical implications of tumor hypoxia extend across every treatment modality. Conventional therapies such as radiation and certain chemotherapies rely on adequate oxygen levels in tumor tissue to generate the reactive molecules that damage cancer cell DNA (11, 12). When oxygen is scarce, these treatments become less effective. At the same time, the very mechanism that defines the potency of these therapies — the generation of reactive oxygen species (ROS) — also causes oxidative damage to healthy tissues, underscoring the importance of supportive strategies to maintain overall oxidative balance during treatment.
But the implications run deeper than that — and this is where the conversation shifts from conventional oncology toward a more integrative understanding. Hypoxia doesn’t just blunt the effects of radiation and drugs. It undermines the body’s own healing infrastructure: the immune surveillance that detects and eliminates abnormal cells, the cellular repair mechanisms that maintain tissue integrity, and the metabolic pathways that sustain energy and vitality during treatment and recovery.
Oxygenation is a central principle in integrative oncology. At Hope4Cancer, it is one of Dr. Jimenez’s 7 Key Principles of Cancer Therapy® — foundational pillars that guide an integrative approach to treatment of the disease (13). Integrative approaches recognize that restoring oxygen to the tumor microenvironment supports the whole system — the immune response, cellular metabolism, tissue repair, and the body’s innate capacity to regulate itself. It’s not about attacking the cancer from one angle; it’s about creating an internal environment where the body’s own defenses can function as they were naturally designed.
The Bridge Between Understanding and Action
Understanding the oxygen paradox is central to thinking differently and more holistically about cancer care. The science tells us that tumors thrive in low-oxygen environments and actively manipulate their surroundings to maintain that advantage. It also tells us that the body possesses sophisticated systems for managing oxidative stress that, when properly supported, can distinguish friend from foe at the molecular level.
The practical question becomes: what can we do about it? The answer, increasingly supported by published research, involves two complementary strategies. The first is the clinical use of targeted oxygenation therapies — such as ozone therapy, hyperbaric oxygen therapy (HBOT), extracorporeal blood ozonation and oxygenation (EBOO) therapy, and ultraviolet blood irradiation (UVBI) — that seek to address the oxygen deficit in and around tumors while activating the body’s own protective mechanisms. The second is making personal changes: lifestyle practices in exercise, nutrition, detoxification, breathing, and emotional and spiritual health that sustain and optimize the body’s oxygen delivery systems between treatments.
When you understand the oxygen paradox, the path forward becomes clear: restoring the body’s oxygen balance isn’t a complementary afterthought — it’s a foundational element of an effective treatment strategy and long-term recovery.
References:
- Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell (6th ed.), 2014, Garland Science, New York, NY.
- Ahmad M, Wolberg A, Kahwaji CI. Biochemistry, Electron Transport Chain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
- Baeza-Noci J, Pinto-Bonilla R. Systemic Review: Ozone: A potential new chemotherapy. Int J Mol Sci 2021, 22(21): 11796. doi:10.3390/ijms222111796
- Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med 2018, 54(4):287–293. doi:10.1016/j.ajme.2017.09.001
- Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 2018, 98(3):1169–1203. doi:10.1152/physrev.00023.2017
- Clavo B, Santana-Rodríguez N, Llontop P, Gutiérrez D, et al. Ozone therapy as adjuvant for cancer treatment: is further research warranted? Evid Based Complement Alternat Med 2018, 7931849. doi:10.1155/2018/7931849
- Zhi S, Chen C, Huang H, et al. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment. Front Immunol 2024, 15:1370800. doi:10.3389/fimmu.2024.1370800
- Shi S, Ou X, Liu C, Wen H, & Ke J. Research progress of HIF-1α on immunotherapy outcomes in immune vascular microenvironment. Front Immunol 2025, 16:1549276. doi:10.3389/fimmu.2025.1549276
- Liberti MV, Locasale JW. The Warburg Effect: how does it benefit cancer cells? Trends Biochem Sci 2016, 41(3):211–218. doi:10.1016/j.tibs.2015.12.001
- Jimenez A, Chakravarty S. Cancer Outsmarted: 11 Integrative Hallmarks to Minimize Risk and Optimize Health, 2025. Envision Health Press, Austin, TX.
- Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer—a review. Target Oncol 2012, 7(4):233–242. doi:10.1007/s11523-012-0233-x
- Cheng X, Wang P, Lyu H, et al. Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance. Cancer Drug Resist 2025, 8:46. doi:10.20517/cdr.2025.132
- Jimenez A. Hope For Cancer: 7 Principles to Remove Fear and Empower Your Healing Journey, 2019. Envision Health Press, Austin, TX.
Disclaimer: The information in this article is provided for educational purposes only and is not intended as medical advice. It does not constitute a recommendation for any specific treatment, therapy, or course of action. The therapies and approaches referenced in this article have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the treatment of cancer. The scientific references cited reflect published research and do not constitute claims of efficacy for any specific condition or treatment protocol. Always consult with a qualified healthcare professional before making decisions about your health or treatment plan.
Authors
